Individualized antianginal therapy guided by systemic arterial pressure.

Area of Science:

• Cardiology
• Pharmacology

Background:

• Antianginal drugs, excluding nitrates, are commonly used as first-line antihypertensive treatments.
• The impact of pretreatment blood pressure on the antianginal efficacy of these drugs is not well-established.

Purpose of the Study:

• To evaluate the relationship between pretreatment blood pressure and the effectiveness of antianginal drugs.
• To determine appropriate initial antianginal therapy for patients with varying blood pressure levels.

Main Methods:

• Review of existing literature on antianginal and antihypertensive drug classes.
• Analysis of potential risks associated with excessive blood pressure reduction in angina treatment.

Main Results:

• Certain antianginal drugs may worsen ischemic conditions by excessively lowering blood pressure.
• Nitrates demonstrate a favorable profile without significant blood pressure-lowering effects.

Conclusions:

• In normotensive and hypotensive patients with angina, initiating treatment with drugs that do not primarily reduce blood pressure is recommended.
• Nitrates represent a suitable option for initial angina management in these patient groups pending further comparative studies.